Top Markets
Coin of the day
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Classement en actions #84
Abbott Laboratories, together with its subsidiaries, discovers, develops,... Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Prix de l'action
$101.91
Capitalisation boursière
$177.09B
Changement (1 jour)
-1.97%
Changement (1 an)
-19.78%
Pays
US
Échange Abbott Laboratories (ABT)

Catégorie

Revenus pour Abbott Laboratories (ABT)
Revenus en Dec 2025 TTM : $44.33B
Selon les derniers rapports financiers de Abbott Laboratories, le chiffre d'affaires actuel de l'entreprise (TTM) est de $44.33B. En 2024, l'entreprise a réalisé un chiffre d'affaires de $41.95B une augmentation par rapport à le chiffre d'affaires de l'année 2023, qui était de $40.11B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Abbott Laboratories de 2000 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $44.33B 0.00%
2025 $44.33B 5.67%
2024 $41.95B 4.59%
2023 $40.11B -8.12%
2022 $43.65B 1.34%
2021 $43.08B 24.47%
2020 $34.61B 8.48%
2019 $31.90B 4.34%
2018 $30.58B 11.64%
2017 $27.39B 31.35%
2016 $20.85B 2.20%
2015 $20.41B 0.78%
2014 $20.25B -7.33%
2013 $21.85B -45.21%
2012 $39.87B 2.63%
2011 $38.85B 10.48%
2010 $35.17B 14.31%
2009 $30.77B 4.19%
2008 $29.53B 13.94%
2007 $25.91B 15.30%
2006 $22.48B 0.62%
2005 $22.34B 13.51%
2004 $19.68B 0.00%
2003 $19.68B 11.29%
2002 $17.68B 8.59%
2001 $16.29B 18.47%
2000 $13.75B 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
$25.12B -43.34%
US
$35.49B -19.93%
IE
$35.48B -19.95%
IE
$20.08B -54.71%
US
$25.70B -42.03%
DE